Scientific Reports,
Journal Year:
2025,
Volume and Issue:
15(1)
Published: April 21, 2025
Abstract
White
mustard
(
Sinapis
alba
L.)
seeds
are
the
most
commonly
used
species
in
herbal
medicine
to
treat
a
wide
range
of
inflammatory
disorders.
Due
its
increased
bioavailability
and
lower
toxicity,
green
biosynthesis
metal
nanoparticles
(M-NPs)
utilizing
plant
extract
as
capping
agent
has
been
demonstrated
over
number
years.
Thus,
current
study
sought
examine
vitro
biological
activity
copper
oxide
(CuO-NPs)
selenium
(Se-NPs)
that
were
biosynthesized
using
aqueous,
methanolic,
petroleum
ether
extracts
from
S.
seeds.
Phytochemical
activities
(antioxidant,
scavenging,
anti-diabetic,
anti-acetylcholinesterase,
anti-arthritic,
anti-inflammatory,
cytotoxic
activities)
assayed
all
prepared
before
after
being
for
M-NPs.
It
was
found
total
methanolic
possessed
highest
compared
other
native
extracts.
The
LC-ESI-MS/MS
analysis
secondary
metabolites
showed
contained
7
phenolic
acids
9
flavonoid
aglycones.
This
helped
find
active
ingredients.
We
characterized
8
acid
derivatives,
glycosides,
4
aliphatic
glucosinolates,
3
aromatic
aryl
glucosinolates
aqueous
extract.
Furthermore,
contains
concentrations
polyphenols,
condensed
tannins,
compounds.
Se-NPs
higher
those
CuO-NPs.
median
lethal
dose
(LD
50
)
studied
appeared
safer
findings
this
concluded
is
suitable
bioresource
biosynthesizing
through
nanotechnology,
with
efficiency
relation
metabolite
fingerprint.
Pharmaceutics,
Journal Year:
2025,
Volume and Issue:
17(2), P. 180 - 180
Published: Feb. 1, 2025
Background/Objectives:
Numerous
diseases
such
as
diabetes,
Alzheimer’s
disease,
and
cancer
have
spread
in
the
whole
world,
especially
Arab
world.
Also,
various
applications
of
Schiff-base
functionalized
nanoparticles
copper
oxide
(CuO-NPs)
therapeutic
been
discovered.
Thus,
current
research
highlights
(i)
synthesis
produced
with
a
Schiff
base
(SB)
serving
capping
agent
during
their
(ii)
assessment
vitro
biological
activities
base-synthesized
(SB-CuO-NPs)
(SB).
Methods:
SB-CuO-NPs
were
characterized
using
ultraviolet-visible
(UV-Vis)
spectroscopy,
zeta
potential,
DLS
analysis,
transmission
electron
microscope
(TEM).
It
also
focuses
on
assessing
activities,
including
antioxidant,
scavenging,
anti-diabetic,
anti-Alzheimer,
anti-arthritic,
anti-inflammatory,
cytotoxic
enzymes
inhibitory
methods
described
literature.
Results:
The
results
compared
those
SB.
demonstrated
superior
when
to
SB
from
which
they
produced.
Conclusions:
this
investigation
concluded
that
CuO-NPs,
synthesized
an
alternative
agent,
exhibited
enhanced
efficacy
relative
original
In
future,
efficiency
against
Alzheimer’s,
will
be
assessed
experimental
animals
(in
vivo).
International Journal of Pharmaceutics,
Journal Year:
2025,
Volume and Issue:
670, P. 125125 - 125125
Published: Jan. 8, 2025
Reduced
docosahexaenoic
acid
(DHA)
concentrations
seem
to
be
associated
with
an
increased
risk
of
Alzheimer's
disease
(AD),
and
DHA
accretion
the
brain
across
blood-brain-barrier
(BBB)
can
modulated
by
various
factors.
Therefore,
there
is
urgent
need
identify
efficient
non-invasive
method
ensure
enrichment.
In
present
study,
a
safe
stable
DHA-enriched
nanoemulsion,
designed
protect
against
oxidation,
was
administered
intranasally
in
transgenic
mouse
model
AD,
J20
mice.
Intranasal
treatment
nanoformulated
significantly
improved
well-being
working
spatial
memory
six-months-old
These
behavioral
effects
were
reduction
amyloid
deposition,
oxidative
stress,
neuroinflammation
tissues,
which
may
partially
due
DHA-induced
inactivation
pleiotropic
kinase
GSK3β.
conclusion,
intranasal
administration
exhibited
strong
therapeutic
disease-modifying
benefits
AD
model.
Given
that
has
already
shown
safety
tolerability
healthy
human
subjects,
our
results
further
support
for
clinical
trials
assess
potential
this
approach
patients.
Designed Monomers & Polymers,
Journal Year:
2024,
Volume and Issue:
28(1), P. 1 - 34
Published: Dec. 31, 2024
This
review
paper
analyzes
recent
advancements
in
bio-polymer
coatings
for
probiotic
microencapsulation,
with
a
particular
emphasis
on
chitosan
and
its
synergistic
combinations
other
materials.
Probiotic
microencapsulation
is
essential
protecting
probiotics
from
environmental
stresses,
enhancing
their
stability,
ensuring
effective
delivery
to
the
gut.
The
begins
an
overview
of
highlighting
significance
safeguarding
through
processing,
storage,
gastrointestinal
transit.
Advances
chitosan-based
encapsulation
are
explored,
including
integration
bio-polymers
such
as
alginate,
gelatin,
pectin,
well
application
nanotechnology
innovative
techniques
like
spray
drying
layer-by-layer
assembly.
Detailed
mechanistic
insights
integrated,
illustrating
how
influences
gut
microbiota
by
promoting
beneficial
bacteria
suppressing
pathogens,
thus
role
prebiotic
or
synbiotic.
Furthermore,
delves
into
chitosan's
immunomodulatory
effects,
particularly
context
inflammatory
bowel
disease
(IBD)
autoimmune
diseases,
describing
immune
signaling
pathways
influenced
linking
changes
improvements
systemic
immunity.
Recent
clinical
trials
human
studies
assessing
efficacy
chitosan-coated
presented,
alongside
discussion
practical
applications
comparison
vitro
vivo
findings
highlight
real-world
relevance.
sustainability
sources
impact
addressed,
along
novel
concept
gut-brain
axis.
Finally,
emphasizes
future
research
needs,
development
personalized
therapies
exploration
techniques.
Artificial Cells Nanomedicine and Biotechnology,
Journal Year:
2025,
Volume and Issue:
53(1), P. 1 - 15
Published: Feb. 9, 2025
Chitosan
nanoparticles
have
been
extensively
utilised
as
polymeric
drug
carriers
in
formulations
due
to
their
potential
enhance
delivery,
efficacy,
and
safety.
Numerous
toxicity
studies
previously
conducted
assess
the
safety
profile
of
chitosan-based
nanoparticles.
These
employed
various
methodologies,
including
test
animals,
interventions,
different
routes
administration.
This
review
aims
summarise
research
on
with
a
focus
general
tests
determine
LD50
NOAEL
values.
It
can
serve
repository
reference
for
nanoparticles,
facilitating
future
further
development
drugs
delivery
system
using
chitosan
Publications
from
2014
2024
were
obtained
PubMed,
Scopus,
Google
Scholar,
ScienceDirect,
accordance
inclusion
exclusion
criteria.The
ARRIVE
2.0
guidelines
evaluate
quality
risk-of-bias
vivo
studies.
The
results
demonstrated
favourable
profiles,
often
exhibiting
reduced
compared
free
or
substances.
Acute
consistently
reported
high
values,
frequently
exceeding
5000
mg/kg
body
weight,
while
subacute
typically
revealed
no
significant
adverse
effects.
Various
administration
varied,
oral,
intravenous,
intraperitoneal,
inhalation,
topical,
each
demonstrating
promising
profiles.